术前额外使用阿奇霉素是否会减少子宫切除术后感染
子宫切除术后感染——一项比较阿奇霉素和头孢呋辛预防性使用与单一头孢呋辛预防性使用的安慰剂对照研究
During hysterectomy bacteria may enter into the peritoneal cavity through vaginal opening and contaminate the healing tissues. The risk for deep infection after hysterectomy is about 5%. By reducing post-hysterectomy infections, it is possible to reduce individual burden of disease in addition to the direct and indirect financial costs. This study primary aim is to assess if prophylactic preoperative use of azithromycin in addition to generally used cefuroxime decreases post-hysterectomy infections as compared to cefuroxime only prophylaxis during 30 days after hysterectomy. Secondary aim is to assess if there is change in post-hysterectomy superficial infections, urinary tract infections, or post-operative fever between the cohorts and to report possible side-effects of the used antibiotics. In addition, the study finds out a possible role of bacterial vaginosis and microbiome n post-hysterectomy infections.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Päivi K Rahkola-Soisalo, Adj prof,MD
- 电话号码:+358504270411
- 邮箱:paivi.rahkola-soisalo@hus.fi
研究联系人备份
- 姓名:Ninja Savonius, MD
- 电话号码:+358503466986
- 邮箱:ninja.savonius@hus.fi
学习地点
-
-
-
Helsinki、芬兰
- 招聘中
- Helsinki University Central Hospital
-
接触:
- Ninja Savonius, MD
- 电话号码:+358503466986
- 邮箱:ninja.savonius@hus.fi
-
接触:
- Päivi K Rahkola-Soisalo, Adj prof,MD
- 电话号码:+358 50 4270411
- 邮箱:paivi.rahkola-soisalo@hus.fi
-
副研究员:
- Liisu Saavalainen, PhD, MD
-
副研究员:
- Päivi Härkki, Adj prof, MD
-
副研究员:
- Tomi Mikkola, Prof, MD
-
副研究员:
- Veli-Jukka Anttila, Adj prof,MD
-
副研究员:
- Seppo Virtanen, DI, MD
-
副研究员:
- Anne Saloranta, Adj Prof
-
副研究员:
- Ilkka Kalliala, Adj Prof, MD
-
副研究员:
- Suvi Niku, PhD, MD
-
Jyväskylä、芬兰、40620
- 招聘中
- Jyväskylä Central Hospital
-
接触:
- Jaana Seikkula, PhD
- 电话号码:+358 41 548 3562
- 邮箱:jaana.seikkula@fimnet.fi
-
Kuopio、芬兰、70029
- 招聘中
- Kuopio University Central Hospital
-
接触:
- Henna Kärkkäinen, PhD
- 电话号码:+358 44 7172741
- 邮箱:henna.karkkainen@kuh.fi
-
Oulu、芬兰、PL23
- 招聘中
- Oulu University Central Hospital
-
接触:
- Sari Koivurova, PhD
- 电话号码:+358 8 3150211
- 邮箱:sari.koivurova@ppshp.fi
-
Tampere、芬兰、33521
- 招聘中
- Tampere University Central Hospital
-
接触:
- Riikka Niemi, PhD
- 电话号码:+358 3 31169083
- 邮箱:riikka.niemi@pshp.fi
-
副研究员:
- Elina Ylilehto, PhD, MD
-
Turku、芬兰
- 招聘中
- Turku University Central Hospital
-
接触:
- Pia Heinonen, PhD
- 电话号码:+358 2 313 5002
- 邮箱:pia.heinonen@tyks.fi
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Women undergoing hysterectomy for benign indication in University Hospitals (Helsinki University Hospital, Turku University Hospital, Tampere University Hospital, Oulu University Hospital and Kuopio University Hospital) who have not any contraindications for azithromycin or cefuroxime.
Exclusion Criteria:
- Inability to understand the study protocol.
- Allergy for either cefuroxime or azithromycin.
- Congenital or acquired prolonged Q-T-corrected interval. All the participants will be asked about arrhythmias and whether they have congenital arrhythmias in the family,
- Electrocardiogram will be checked for all the participants.
- Use of medicines that may prolong Q-T-corrected interval (class Ia arrhythmia medications, quinidine, procainamide, and class III arrhythmia medications dofetilide, amiodarone and sotalol).
- Use of selective serotonin reuptake inhibitor medication and prolonged Q-T-corrected interval.
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Azithromycin + Cefuroxime
Changed with renewed study permissions: These patients will receive Azithromycin 500 mg (2 tablets) per orally on the operation day when they arrive to the hospital and a single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose bosy mass index is 30 or more) in the operating theatre before the incision. The previous description: These patients will receive Azithromycin 500 mg (2 tablets) per orally in the evening before the operation and single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose body mass index is 30 or more) in the operating theatre before the incision. |
Azithromycin 500 mg (2 tablets) per orally when arriving to the hospital before the operation and a single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose body mass index is 30 or more) in the operating theatre before the incision |
|
有源比较器:Placebo + Cefuroxime
Changed with new study permissions: These patients will receive placebo (2 tablets) per orally on the operation day when they arrive to the hospital and a single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose bosy mass index is 30 or more)in the operating theatre before the incision. The previous description: These patients will receive placebo (2 tablets) per orally in the evening before the operation and a single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose body mass index is 30 or more) in the operating theatre before the incision. |
Placebo (2 tablets) per orally in the evening when arriving to the hospital before the operation and a single dose Cefuroxime 1.5g (when body mass index is under 30) or 3g (for those whose body mass index is 30 or more) in the operating theatre before the incision |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of post-hysterectomy episodes with deep infections
大体时间:Deep infections that occur between the first and 30th postoperative day after hysterectomy
|
Number of deep wound and pelvic organ infection episodes reported by patients and doctors |
Deep infections that occur between the first and 30th postoperative day after hysterectomy
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of other post-hysterectomy infections or fever episodes
大体时间:Number of other infections or fever episodes that occur between the first and 30th postoperative day after hysterectomy.
|
Number of superficial infections, other infections, such has urine tract infections, or fever episodes lasting over 38 ℃ over 2 days |
Number of other infections or fever episodes that occur between the first and 30th postoperative day after hysterectomy.
|
合作者和调查者
合作者
调查人员
- 首席研究员:Päivi Rahkola-Soisalo, Adj prof, MD、Helsinki University Central Hospital
- 学习椅:Tomi Mikkola, Prof, MD、Helsinki University Central Hospital
- 研究主任:Päivi Rahkola-Soisalo, Adj prof, MD、Helsinki University Central Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.